MACKENZIE FINANCIAL CORP

Position in PTCT — Ptc Therapeutics, Inc.

CIK 919859 TORONTO ONTARIO, A6

Position in PTCT

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$23,551,382

+$5,555,775 QoQ

Shares Held

345,683

+45.9% QoQ

Ownership

4.17%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MACKENZIE FINANCIAL CORP holds $416,722,148 across 43 Biotechnology names. PTCT ranks #6 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	1,779,636	$93,003,777
2	REGN	Regeneron Pharmaceuticals, Inc.	86,317	$66,691,966
3	INCY	Incyte Corp	549,633	$51,731,457
4	VRTX	Vertex Pharmaceuticals Inc / Ma	96,709	$43,184,436
5	BMRN	Biomarin Pharmaceutical Inc	441,444	$24,937,171
6	PTCT	Ptc Therapeutics, Inc. This page	345,683	$23,551,382
7	MRVI	Maravai Lifesciences Holdings, Inc.	6,306,425	$17,847,182
8	RPRX	Royalty Pharma plc	170,882	$8,197,209

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,551,382	345,683	+45.9%	Shares	Sole	2026-05-13
2025-12-31	$17,995,607	236,909	+17.4%	Shares	Sole	2026-02-18
2025-09-30	$12,383,975	201,792	+667.7%	Shares	Sole	2025-11-13
2025-06-30	$1,283,808	26,286	+0.7%	Shares	Sole	2025-08-13
2025-03-31	$1,329,648	26,092	+14.6%	Shares	Sole	2025-05-07
2024-12-31	$1,028,108	22,776	+132.2%	Shares	Sole	2025-05-02
2024-09-30	$363,913	9,809	+4.7%	Shares	Sole	2024-11-13
2024-06-30	$286,504	9,369	+66.5%	Shares	Sole	2024-08-14
2023-06-30	$228,850	5,627	-59.0%	Shares	Sole	2023-08-03
2023-03-31	$665,032	13,729	+131.6%	Shares	Sole	2023-04-24
2022-12-31	$226,309	5,929	+24.5%	Shares	Sole	2023-02-14
2022-09-30	$239,002	4,761	—	Shares	Sole	2022-10-07
No filing history on record for this holder in this stock.